Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.13
0.00 (0.00%)
At close: Aug 20, 2025, 9:40 AM
Marker Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 5.39M | 5.7M | 6.59M | 5.4M | 3.73M | 3.32M | 5.58M | 10.58M | 14.27M | 14.3M | 11.76M | 6.95M | 3M | 2.21M | 1.24M | 215.00 | 215.00 | 467K |
Cost of Revenue | 8.56M | 10.89M | 13.47M | 11M | 9.57M | 9.62M | 8.01M | 6.36M | 7.91M | 6.37M | 6.23M | 6.09M | 3.3M | 3.24M | 3.16M | 8.33M | 12.32M | 15.82M |
Gross Profit | -4.03M | -5.2M | -6.88M | -5.6M | -5.84M | -6.29M | -1.2M | 5.45M | 10.14M | 11.71M | 8.08M | 3.41M | -301.65K | -1.04M | -1.92M | -8.32M | -12.32M | -15.35M |
Operating Income | -15.13M | -13.18M | -11.12M | -10.2M | -10.99M | -12.82M | -15.32M | -16.24M | -18.86M | -24.01M | -28.75M | -34.66M | -38.86M | -40.49M | -39.48M | -38.22M | -35.57M | -31.02M |
Interest Income | 455.94K | 443.3K | 437.01K | 564.6K | 691.01K | 610.7K | 539.16K | 447.23K | 328.89K | 329.6K | 248.06K | 139.62K | 40.66K | 7.28K | 5.7K | 5.98K | 9.86K | 23.31K |
Pretax Income | -14.56M | -12.73M | -10.68M | -9.63M | -10.3M | -12.21M | -14.79M | -15.09M | -19.03M | -24.18M | -29.12M | -35.84M | -41.35M | -43.01M | -41.88M | -40.62M | -35.56M | -31M |
Net Income | -14.61M | -12.79M | -10.73M | -9.7M | -10.37M | -5.66M | -8.15M | -9.35M | -13.28M | -25.01M | -30.03M | -35.8M | -41.31M | -43.01M | -41.88M | -40.62M | -35.56M | -31M |
Selling & General & Admin | 4.2M | 4.39M | 4.24M | 4.59M | 5.15M | 6.53M | 7.83M | 8.34M | 10.16M | 11.16M | 12.38M | 13.47M | 13.48M | 13.52M | 12.93M | 12.46M | 11.79M | 10.78M |
Research & Development | 15.87M | 14.03M | 13.47M | 11M | 9.57M | 9.62M | 14.31M | 16.96M | 18.51M | 22.68M | 22.44M | 25.19M | 28.38M | 29.18M | 27.79M | 25.76M | 23.78M | 20.71M |
Other Expenses | -8.96M | -9.27M | -10.97M | -6.94M | -3.73M | -3.32M | -3.31M | 499K | 757K | 729K | 999K | -9.77M | -12.18M | -18.74M | -17.77M | -15.74M | -13.33M | -5.98M |
Operating Expenses | 11.1M | 10.32M | 9.15M | 9.5M | 10.06M | 10.72M | 11.23M | 16.26M | 20.67M | 25.82M | 31.3M | 35.91M | 40.1M | 41.73M | 40.72M | 38.22M | 35.57M | 31.49M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.66M | 18.87M | 17.71M | 15.59M | 14.46M | 15.12M | 19.88M | 25.8M | 33.57M | 38.72M | 39.96M | 41.05M | 40.1M | 41.73M | 40.72M | 38.22M | 35.57M | 31.49M |
Income Tax Expense | 49.95K | 49.95K | 49.95K | 3.67K | 3.67K | 3.67K | -80.33K | 54.65K | 205.26K | 169.47K | 250.35K | 110.73K | -40.66K | -7.28K | -5.7K | -5.98K | -9.86K | -23.31K |
Shares Outstanding (Basic) | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.17M | 8.29M | 8.3M | 5.65M |
Shares Outstanding (Diluted) | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.31M | 8.31M | 8.3M | 5.65M |
EPS (Basic) | -1.37 | -1.33 | -1.2 | -1.09 | -1.17 | -0.63 | -0.93 | -1.1 | -1.59 | -2.99 | -3.61 | -4.32 | -4.99 | -5.18 | -5.59 | -6.15 | -6.25 | -6.35 |
EPS (Diluted) | -1.37 | -1.33 | -1.2 | -1.09 | -1.17 | -0.63 | -0.93 | -1.1 | -1.59 | -2.99 | -3.61 | -4.3 | -4.97 | -5.16 | -5.57 | -6.15 | -6.25 | -6.35 |
EBITDA | -8.38M | -6.42M | -4.53M | -10.2M | -10.99M | -12.82M | -13.76M | -13.71M | -16.34M | -16.89M | -22.36M | -27.18M | -30.57M | -36.01M | -35.07M | -35.41M | -33.18M | -28.81M |
EBIT | -8.38M | -6.42M | -4.53M | -9.99M | -10.79M | -12.58M | -15M | -16.12M | -19.84M | -24.99M | -29.82M | -34.48M | -37.59M | -39.25M | -38.24M | -38.22M | -35.57M | -30.55M |
Depreciation & Amortization | n/a | n/a | 2.55M | 3.25M | 3.94M | 4.76M | 3.18M | 3.45M | 3.57M | 3.6M | 3.46M | 3.31M | 3.3M | 3.24M | 3.16M | 2.81M | 2.15M | 1.46M |